mRNA |
EKB-569 |
GDSC1000 |
pan-cancer |
AAC |
0.17 |
8e-06 |
mRNA |
ABT-263 |
CTRPv2 |
pan-cancer |
AAC |
0.18 |
9e-06 |
mRNA |
tretinoin:navitoclax (4:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.17 |
1e-05 |
mRNA |
navitoclax:PLX-4032 (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.17 |
1e-05 |
mRNA |
BRD-K28456706 |
CTRPv2 |
pan-cancer |
AAC |
0.18 |
2e-05 |
mRNA |
BRD-A02303741:navitoclax (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.17 |
3e-05 |
mRNA |
MI-2 |
CTRPv2 |
pan-cancer |
AAC |
0.24 |
4e-05 |
mRNA |
decitabine:navitoclax (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.15 |
4e-05 |
mRNA |
lovastatin |
CTRPv2 |
pan-cancer |
AAC |
-0.17 |
4e-05 |
mRNA |
BYL-719 |
CTRPv2 |
pan-cancer |
AAC |
0.2 |
5e-05 |